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meloblastic  ﬁbrodentinosarcoma  (AFDS)  is  a  rare  odonto-
enic  tumor  histologically  characterized  by  a  sarcomatous
ctomesenchymal  component  associated  with  variable
mounts  of  benign  ameloblastomatous  epithelium  and  the
resence  of  dysplastic  dentin.1 About  14  cases  have  been
eported  in  the  medical  literature.  The  etiology  of  the  AFDS
s  poorly  understood;  however,  approximately  one-third  of
FDS  appear  to  represent  the  malignant  transformation  of
re-existing  ameloblastic  ﬁbrodentinoma.1,2
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ccess article under the CC BY license (http://creativecommons.org/licAFDS  has  a  predilection  for  the  mandible,  and  it  is  most
ommonly  seen  in  male  patients  in  the  third  decade  of
ife.  Patients  often  present  with  a  painful  swelling,  and
FDS  is  radiographically  characterized  by  a  multilocular
adiolucent  lesion  with  indistinct  margins,  with  or  without
adiopaque  foci.  Metastases  are  rare,  but  recurrences  have
een  reported.  The  treatment  of  choice  is  wide  surgical
esection.3
Given  the  above,  the  aim  of  this  report  is  to  describe  a
ase  of  aggressive  mandibular  AFDS  with  emphasis  on  clini-
al,  radiological,  and  histopathological  aspects.
ase report
 19-year-old  man  was  referred  to  public  service  for  oral
athology  consultation  in  2014.  The  extraoral  inspection
howed  a  large  swelling  with  strong  facial  asymmetry  on  left
ide  of  the  face  (Fig.  1).  Intraorally,  an  extensive  ulcerated
nd  necrotic  mass  was  observed  from  the  tooth  35  extend-
ng  to  the  mandible  body  and  ramus,  with  clinical  absence
f  teeth  36,  36,  and  38.  Despite  the  presence  of  ulceration,
a Ce´rvico-Facial. Published by Elsevier Editora Ltda. This is an open
enses/by/4.0/).
Ameloblastic  ﬁbrodentinosarcoma  611
Figure  3  Histopathological  ﬁndings.  Biphasic  pattern  with
benign  odontogenic  epithelium  surrounded  by  sarcomatous
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dFigure  1  Clinical  ﬁndings.  Front  view  of  the  patient  showing
marked  facial  asymmetry.
the  patient  only  reported  pain  on  palpation,  and  limitation
in  mouth  opening  was  noted.  There  was  no  clinical  evidence
of  regional  lymphadenopathy.
The  radiographic  exam  revealed  an  ill-deﬁned  radi-
olucency  measuring  about  7  cm  ×  4.5  cm  associated  with
impacted  molar  (36),  lacking  sclerotic  borders  and  asso-
ciated  with  the  presence  of  multiple  radiopaque  ﬂecks.
Expansion  and  thinning  of  cortical  bone  were  also  observed
(Fig.  2).  Calcifying  epithelial  odontogenic  tumor,  calcifying
odontogenic  cyst,  and  ameloblastic  ﬁbrodontoma  were  the
main  clinical  differential  diagnoses  considered.
An  incisional  biopsy  was  performed  and  submitted  to
histopathological  exam.  Microscopic  examination  of  the  sec-
tions  routinely  stained  in  hematoxylin  and  eosin  revealed  a
biphasic  neoplastic  proliferation  of  odontogenic  epithelial
and  mesenchymal  tissue.  The  odontogenic  epithelial  com-
ponent  consisted  of  multiple  cords  and  islands  bounded  by
Figure  2  Panoramic  radiograph  showing  multilocular  exten-
sive radiolucent  lesion  with  radiopaque  foci  in  the  left
mandible,  associated  with  impacted  molar  (36).
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domponent  with  intense  cellular  and  nuclear  pleomorphism  and
itotic  ﬁgures  (H&E  stain,  200×).
olumnar  to  cuboidal  ameloblast-like  cells,  with  reversed
uclear  polarity.  In  the  center  of  these  structures,  the
eoplastic  cells  had  a  loose  aspect,  resembling  the  stel-
ate  reticulum  of  the  enamel  organ.  The  mesenchymal
omponent  consisted  of  a  primitive  connective  tissue  that
isplayed  marked  pleomorphism  characterized  by  variation
n  cell  size  and  shape,  as  well  as  nuclear  hyperchro-
atism,  alteration  in  nuclear  to  cytoplasmic  ratio,  and
cattered  mitotic  ﬁgures  (Fig.  3).  Areas  of  necrosis  focus
ere  identiﬁed.  Juxta-epithelial  hyalinization  was  evident
n  few  areas.  Focal  areas  of  dentinoid-like  material  with
ubules  were  also  observed  (Fig.  4).  Enamel  formation  could
ot  be  identiﬁed,  even  on  multiple  sections.  Furthermore,
meloblastic  ﬁbroma  areas  were  present.  Therefore,  clini-
al,  radiographic,  and  histopathological  ﬁndings  supported
he  diagnosis  of  ameloblastic  ﬁbrodentinosarcoma.
The  oncologist  and  surgeon  chose  to  perform  chemother-
py  previous  to  the  surgical  treatment.  Initially,  three  cycles
f  a  drug  combination  were  administered,  comprising  vin-
ristine,  cyclophosphamide,  and  cloxorubicin.  The  patient
id  not  respond  well  to  initial  treatment  and  did  not  appear
or  the  surgery  on  the  day  scheduled,  returning  only  after
our  weeks.  Thus,  a new  combination  of  drugs  in  three  cycles
igure  4  Histopathological  aspects  showing  deposition  of
entinoid-like  material.  (H&E  stain,  200×).
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Figure  5  Craniocaudal  view  of  the  patient  showing  a  sig-
n
c
w
e
f
t
e
a
i
o
a
l
m
l
n
l
s
t
w
h
t
h
D
O
h
s
o
p
t
e
s
o
p
i
i
e
e
o
m
d
O
d
c
(
e
p
t
i
o
c
r
a
w
c
l
r
g
c
c
g
w
t
p
p
r
f
t
3
q
w
t
l
h
1
m
c
s
t
c
i
w
A
n
t
d
11iﬁcant  increase  in  tumor  mass  after  eight  sessions  of
hemotherapy.
as  instituted,  consisting  of  ifosfamide,  carboplatin,  and
toposide  in  order  to  reduce  tumor  size  before  surgery.
However,  after  two  cycles  of  chemotherapy  with  dif-
erent  drugs,  the  patient  showed  a  signiﬁcant  increase  in
umor  mass  with  skin  invasion,  limited  mouth  opening,  and
xtreme  facial  deformity  (Fig.  5).  After  the  unexpected
ggressive  evolution  of  the  tumor,  surgeons  performed  rad-
cal  left  hemimandibulectomy  with  peripheral  myotomy
f  the  muscle  insertions  associated  with  resection  of  the
ffected  skin.  The  bone  margin  of  3  cm  before  the  mandibu-
ar  symphysis  and  the  peripheral  muscles  removed  with  a
argin  of  2  cm  were  tumor-free.  The  left  inferior  alveo-
ar  nerve  was  involved  by  the  tumor;  however,  there  was
o  presence  of  invasion  of  blood  or  lymphatic  vessels.  Ipsi-
ateral  supraomohyoid  neck  dissection  of  18  lymph  nodes
howed  no  tumor  cells.  The  patient  underwent  postopera-
ive  radiotherapy  with  6000  Gy.
The  patient  has  been  re-evaluated  every  three  months
ith  chest  X-ray  and  CT  scan  of  the  head  and  neck.  There
as  been  no  evidence  of  regional  or  distant  metastasis,  and
he  patient  has  been  under  clinical  follow-up  for  one  and  a
alf  years.
iscussion
dontogenic  tumors  (OT)  consist  of  a  group  of  rare  and
eterogeneous  lesions,  representing  less  than  4%  of  all
pecimens  of  the  oral  and  maxillofacial  region.  Malignant
dontogenic  neoplasms  are  even  rarer  and  constitute  a small
ercentage  of  OT.  In  various  series  published  worldwide,
he  frequency  varies  between  0%  and  6.1%.4 The  pathogen-
sis  of  malignant  OT  is  unclear,  although  some  authors  have
uggested  alterations  in  cellular  cycle,  expression  of  proto-
ncogenes,  and  mutations  in  tumor  suppressor  genes  in  the
athogenesis  of  these  lesions.4
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Microscopically,  the  bland  epithelial  component  of  AFDS
s  similar  to  that  seen  in  ameloblastic  ﬁbrosarcoma,  although
t  is  less  frequent.5,6 The  deﬁnitive  diagnosis  of  AFDS  is
stablished  based  on  histopathologic  evaluation  of  the  mes-
nchymal  component,  which  usually  demonstrates  features
f  malignancy,  including  cellular  atypia,  pleomorphism,  and
itotic  ﬁgures.  In  addition,  when  a  material  similar  to  the
entinoid  is  observed,  the  ﬁnal  diagnosis  should  be  AFDS.7,8
Despite  the  morphological  differences,  the  World  Health
rganization  (WHO)  distinguishes  odontogenic  sarcoma
evoid  of  dental  hard  tissue  (ameloblastic  ﬁbrosar-
oma)  from  those  displaying  focal  evidence  of  dentinoid
ameloblastic  ﬁbrodentinosarcoma)  or  dentinoid  plus  enam-
loid  (ameloblastic  ﬁbro-odontosarcoma),  but  the  WHO
anel  acknowledges  that  presence  or  absence  of  dental  hard
issue  in  an  odontogenic  sarcoma  is  of  no  prognostic  signif-
cance.  The  literature  reports  that  the  biological  behavior
f  the  AFDS  is,  in  general,  similar  to  other  odontogenic  sar-
omas,  with  high  local  aggressiveness  and  low  potential  for
egional  lymph  node  involvement  or  distant  metastasis.6--8
Radiographically,  AFDS  can  show  a  uni-  or  multilocular
ppearance,  with  poorly  circumscribed  outlines  associated
ith  tooth  and  one  or  more  dense  opacities.  The  present
ase  showed  a  multilocular  appearance  associated  with  the
eft  lower  ﬁrst  molar  (36)  and  slight  dense  opacities.  These
adiographic  ﬁndings  and  the  location  of  the  mass  highly  sug-
est  the  possibility  of  odontogenic  cysts  and  tumor.3,8 The
linico-radiographic  differential  diagnosis  should  include
alcifying  epithelial  odontogenic  tumor,  calcifying  odonto-
enic  cyst,  and  ameloblastic  ﬁbrodontoma.  However,  a  case
ith  an  irregular  border  and  expansion  and  perforation  of
he  cortexes  should  be  interpreted  with  caution,  and  the
ossibility  of  malignant  odontogenic  tumor  should  be  sus-
ected.
The  mean  age  at  the  time  of  diagnosis  of  AFDS  in  62  cases
eviewed  by  Bregni  et  al.7 was  27.3  in  a  wide  age  range,
rom  3  to  83  years.  According  to  these  62  published  cases,
he  tumor  is  more  common  in  males  than  females  (59.7%  vs.
7.1%).  Furthermore,  odontogenic  sarcomas  are  more  fre-
uent  in  the  mandible  (79%  of  cases)  than  the  maxilla  (21%),
ith  the  majority  of  the  cases  located  in  posterior  region  of
he  mandible.9
Odontogenic  sarcomas  are  reported  as  a highly  recurrent
esion.  Till  date,  25  (35%)  of  the  71  reported  cases  have
ad  at  least  one  recurrence  during  follow-up  period  and
4  patients  (19.7%)  have  died  of  their  disease  within  three
onths  to  19  years.  Clinical  ﬁndings  vary  among  reported
ases,  but  usually  signs  and  symptoms  include  pain  and
welling.  Despite  regional  lymph  node  involvement  or  dis-
ant  metastases  reported  in  few  cases,  some  authors  have
onsidered  AFDS  as  a  low-grade  sarcoma.2--8
In  a  recent  multicenter  epidemiological  study  conducted
n  Latin  America,  25  cases  of  malignant  odontogenic  tumors
ere  reported,  and  six  cases  were  odontogenic  sarcomas.
ll  cases  had  the  diagnosis  of  ameloblastic  ﬁbrosarcoma  and
o  case  of  AFDS  was  identiﬁed.10 In  addition,  in  a  retrospec-
ive  study  conducted  in  Brazil,  240  odontogenic  tumors  were
escribed;  however,  no  cases  of  odontogenic  sarcoma  were
ound.
The  treatment  of  choice  for  AFDS  is  radical  surgical  exci-
ion  without  primary  neck  dissection.  Some  investigators
ecommend  adjuvant  chemotherapy  and/or  radiotherapy,
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but  its  beneﬁts  are  uncertain.3 Owing  to  the  rarity  of  cases,
it  is  difﬁcult  to  accurately  estimate  long-term  prognosis.
Particularly  in  this  case,  the  patient  did  not  satisfactorily
respond  to  chemotherapy  before  surgery,  leading  to  clini-
cal  worsening  and  increased  tumor  aggressiveness;  this  fact
emphasizes  the  dilemma  of  whether  or  not  the  adjuvant
chemotherapy  should  be  indicated  in  the  treatment  of  these
sarcomas.
Conclusion
In  summary,  this  case  report  describes  the  ﬁrst  case  of  AFDS
in  Brazil  and  emphasizes  the  importance  of  considering  the
odontogenic  sarcomas  as  a  differential  diagnosis  of  maxil-
lary  osteolytic  lesions,  despite  being  extremely  rare  lesions.
Thus,  these  lesions  are  a  challenging  diagnosis  for  clinicians
and  pathologists.
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